Suppr超能文献

消瘕散通过下丘脑细胞衰老相关坏死性凋亡改善 CUMS 诱导的抑郁样和厌食行为。

Xiaoyaosan ameliorates CUMS-induced depressive-like and anorexia behaviors in mice via necroptosis related cellular senescence in hypothalamus.

机构信息

School of Traditional Chinese Medicine, Hainan Medical University, Haikou 571199, China.

School of Traditional Chinese Medicine, Hainan Medical University, Haikou 571199, China; Dongfang Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100078, China.

出版信息

J Ethnopharmacol. 2024 Jan 10;318(Pt A):116938. doi: 10.1016/j.jep.2023.116938. Epub 2023 Jul 24.

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE

Depression and anorexia often co-occur and share symptoms such as low mood, lack of energy, and weight loss. Xiaoyaosan is a classic formula comprising of a combination of eight herbs, possessing definitive therapeutic effects, minimal side effects, and economical benefits. It has been extensively employed in clinical treatment of ailments and symptoms such as depression, anxiety, and appetite problems. Nonetheless, its exact pharmacological mechanism with necroptosis remains incompletely explicit.

AIM OF THE STUDY

The aim of this study is to explore the potential mechanisms of anti-depressive and appetite-regulating effects of the active ingredients in Xiaoyaosan, and to investigate whether there is a correlation with necroptosis.

MATERIALS AND METHODS

The network pharmacology method was conducted to identify active ingredients, which were used to predict the possible targets of Xiaoyaosan and explore the potential targets in treating depression and anorexia by overlapping with differentially expressed genes (DEGs) screened from GEO datasets (GSE125441, GSE198597, and GSE69151). Afterwards, the protein-protein interaction (PPI) network, enrichment analyses, hub gene identification, co-expression study and molecular docking were used to study the potential mechanism of Xiaoyaosan. Then, a mice model of depression was established by chronic unpredictable mild stress (CUMS) and the incidence of necroptosis in the hypothalamus of CUMS mice was investigated, while verifying the key therapeutic target of Xiaoyaosan.

RESULTS

Through network pharmacology research, it had been discovered that the 145 active ingredients of the 8 herbs in the Xiaoyaosan could regulate 198 disease targets. Through PPI network analysis and functional enrichment analysis, it had been found that the pharmacological mechanism of Xiaoyaosan mainly involved biological processes such as oxidative stress, kinase activity, and DNA metabolism. It is related to various pathways such as cellular senescence, immune inflammation, and the cell cycle, and 9 hub targets had been identified. Further analysis of the 9 hub targets and the key PPI network clusters clarified the key mechanisms by which Xiaoyaosan exerts anti-depressant and appetite regulating effects, possibly related to necroptosis-mediated cellular senescence. Molecular docking of the key indicators of cellular senescence screened by bioinformatics, SIRT1, ABL1, and MYC, revealed that the key component regulating SIRT1 is 2-[3,4-dihydroxyphenyl]-5,7-dihydroxy-6-[3-methylbut-2-enyl]chromone in licorice root, Glabridin in licorice root regulates ABL1, and β-sitosterol found in Chinese angelica, debark peony root, and fresh ginger regulates MYC. Finally, through in vivo experiments, the expression of necroptosis in the hypothalamus of CUMS mice was verified. The regulatory effects of Xiaoyaosan on key substances RIPK1, RIPK3, MLKL, and p-MLKL were determined, while regulating effects on SIRT1, ABL1, and MYC were also observed.

CONCLUSION

The present study have revealed the common mechanism of Xiaoyaosan in treating depression and anorexia, indicating that the active ingredients of Xiaoyaosan may alleviate the symptoms of depression and anorexia by intervening in the pathways related to necroptosis and cellular senescence. The hub genes and common pathways identified by the study also provide new insights into the therapeutic targets of depression and anorexia, as well as the exploration of pharmacological mechanism of Xiaoyaosan.

摘要

民族药理学相关性

抑郁症和厌食症常同时发生,并具有情绪低落、缺乏活力和体重减轻等共同症状。逍遥散是一种经典的方剂,由八种草药组成,具有明确的治疗效果、最小的副作用和经济效益。它已广泛应用于抑郁症、焦虑症和食欲问题等疾病和症状的临床治疗。然而,其与细胞坏死相关的确切药理学机制尚不完全明确。

研究目的

本研究旨在探讨逍遥散中活性成分抗抑郁和调节食欲的潜在机制,并探讨其与细胞坏死是否存在相关性。

材料与方法

采用网络药理学方法识别活性成分,预测逍遥散的可能靶点,并通过重叠 GEO 数据集(GSE125441、GSE198597 和 GSE69151)中筛选出的差异表达基因(DEGs)探讨其治疗抑郁症和厌食症的潜在靶点。然后,通过蛋白质-蛋白质相互作用(PPI)网络、富集分析、枢纽基因识别、共表达研究和分子对接来研究逍遥散的潜在机制。随后,通过慢性不可预知性温和应激(CUMS)建立抑郁症小鼠模型,研究 CUMS 小鼠下丘脑细胞坏死的发生率,并验证逍遥散的关键治疗靶点。

结果

通过网络药理学研究,发现 8 种草药中的 145 种活性成分可调节 198 种疾病靶点。通过 PPI 网络分析和功能富集分析,发现逍遥散的药理机制主要涉及氧化应激、激酶活性和 DNA 代谢等生物学过程。它与细胞衰老、免疫炎症和细胞周期等多种途径相关,确定了 9 个枢纽靶点。进一步分析 9 个枢纽靶点和关键 PPI 网络簇,阐明了逍遥散发挥抗抑郁和调节食欲作用的关键机制,可能与细胞坏死介导的细胞衰老有关。通过生物信息学筛选的细胞衰老关键指标 SIRT1、ABL1 和 MYC 的分子对接表明,调节 SIRT1 的关键成分是甘草根中的 2-[3,4-二羟基苯基]-5,7-二羟基-6-[3-甲基-2-丁烯基]色酮,甘草根中的 Glabridin 调节 ABL1,而中国当归、去皮牡丹根和鲜姜中的β-谷甾醇调节 MYC。最后,通过体内实验验证了 CUMS 小鼠下丘脑细胞坏死的表达。确定了逍遥散对 RIPK1、RIPK3、MLKL 和 p-MLKL 等关键物质的调节作用,同时也观察到对 SIRT1、ABL1 和 MYC 的调节作用。

结论

本研究揭示了逍遥散治疗抑郁症和厌食症的共同机制,表明逍遥散的活性成分可能通过干预与细胞坏死和细胞衰老相关的途径来缓解抑郁症和厌食症的症状。该研究确定的枢纽基因和共同途径也为抑郁症和厌食症的治疗靶点以及逍遥散的药理学机制探索提供了新的见解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验